Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

CLEANSLATE MEDICAL GROUP OF PENNSYLVANIA LLC

NPI: 1184177263 · WILKES BARRE, PA 18702 · Addiction Medicine (Internal Medicine) Physician · NPI assigned 07/26/2016

$18.61M
Total Medicaid Paid
276,990
Total Claims
215,416
Beneficiaries
23
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialSMOLAREK, MATTHEW (CFO)
NPI Enumeration Date07/26/2016

Related Entities

Other providers sharing the same authorized official: SMOLAREK, MATTHEW

ProviderCityStateTotal Paid
CLEANSLATE MEDICAL GROUP OF INDIANA LLC ALEXANDRIA IN $79.21M
TOTAL WELLNESS CENTERS, LLC HOLYOKE MA $77.17M
TOTAL WELLNESS CENTERS, LLC WEST SPRINGFIELD MA $38.42M
CLEANSLATE MEDICAL GROUP OF WISCONSIN, SC GLENDALE WI $17.13M
CLEANSLATE MEDICAL GROUP OF KENTUCKY PLLC LOUISVILLE KY $10.48M
CLEANSLATE MEDICAL GROUP OF OHIO LLC MORAINE OH $9.53M
CLEANSLATE MEDICAL GROUP OF VIRGINIA, LLC MECHANICSVILLE VA $4.28M
CLEANSLATE MEDICAL GROUP OF ARIZONA PLLC GILBERT AZ $955K
CLEANSLATE MEDICAL GROUP OF ARIZONA PLLC PHOENIX AZ $248K
CLEANSLATE MEDICAL GROUP OF ARIZONA PLLC PHOENIX AZ $101K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 3,912 $5K
2019 739 $2K
2020 14,875 $1.09M
2021 70,765 $5.37M
2022 74,487 $5.14M
2023 61,078 $3.97M
2024 51,134 $3.04M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 163,162 120,325 $8.47M
G9012 Other specified case management service not elsewhere classified 25,701 25,575 $6.83M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 61,980 50,702 $2.10M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 11,288 5,925 $689K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 3,167 2,650 $198K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 944 787 $67K
99340 341 319 $48K
90834 Psychotherapy, 45 minutes with patient 649 387 $48K
T2023 Targeted case management; per month 441 441 $44K
G9002 Coordinated care fee, maintenance rate 246 243 $36K
90832 Psychotherapy, 30 minutes with patient 881 649 $31K
81025 5,182 4,821 $19K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1,705 1,618 $17K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 212 143 $5K
Q3014 Telehealth originating site facility fee 272 253 $4K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 115 102 $3K
T1016 Case management, each 15 minutes 126 108 $2K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 24 24 $690.69
99406 65 53 $427.50
H2015 Comprehensive community support services, per 15 minutes 326 167 $360.00
87340 12 12 $171.49
H0038 Self-help/peer services, per 15 minutes 121 98 $9.00
99205 Prolong outpt/office vis 30 14 $0.00